Centene is trading 4.22% up at $70.90 after reporting third-quarter 2026 adjusted earnings of $0.58 per share, well above the $0.10 analyst estimate. - Raised its full-year adjusted EPS guidance floor to greater than $5.20 from greater than $4.80. - Improved its expected health benefits ratio midpoint to 90.75%. - The earnings beat and stronger outlook were the clear company-specific catalysts for the October 27 move.